Blog

Cellebrite DI (NASDAQ:CLBT) reported first-quarter 2026 results that management said met or exceeded the high end of its guidance for annual recurring revenue and adjusted EBITDA, while executives

• 4 Blockchain Stocks That Aren’t Coinbase

Bitdeer Technologies Group (NASDAQ:BTDR) reported sharply higher first-quarter revenue as its Bitcoin mining output expanded, while management emphasized a

BioHarvest Sciences (NASDAQ:BHST) reported higher first-quarter revenue and reiterated its 2026 outlook as management detailed a broader reorganization around two business lines: its

Autolus Therapeutics (NASDAQ:AUTL) reported higher first-quarter 2026 product revenue and said its commercial launch of AUCATZYL is gaining traction in the U.S. and U.K., while reiterating

Aquestive Therapeutics (NASDAQ:AQST) said it remains on track to resubmit its new drug application for Anaphylm, its epinephrine sublingual film for severe allergic reactions, in the third quarter

Aebi Schmidt (NASDAQ:AEBI) reported higher first-quarter 2026 order intake, sales and profitability, with management pointing to strong demand in Europe and the rest of the world, improving walk-in

• AeroVironment Touches Down On Value Opportunity

AeroVironment (NASDAQ:AVAV) Chairman, President and CEO Wahid Nawabi said accelerating global security threats are reshaping defense priorities

• Despite Downturns, Analysts Say These 4 Financial Stocks Are Buys

Reinsurance Group of America (NYSE:RGA) reported a strong first quarter of 2026, with management pointing to broad-based earnings

• Dueling Insider Moves: Heavy Buying Here, Big Selling There

Resideo Technologies (NYSE:REZI) reported first-quarter 2026 results above its outlook ranges and reaffirmed its full-year guidance, as

Versant (NASDAQ:VSNT) Media Group reported a modest revenue decline in its first quarter as an independent company, while management pointed to stronger profitability, growth in digital and

• AIRO Group's Pullback: An Undervalued Growth Opportunity?

AIRO Group (NASDAQ:AIRO) reported first-quarter 2026 revenue that declined from the prior year, while management said the results were in

RPC (NYSE:RES) reported higher first-quarter 2026 revenue as activity improved across most service lines despite winter storms early in the period, while profitability was pressured by job mix

Accelerant (NYSE:ARX) reported stronger-than-expected first-quarter 2026 results, with management pointing to continued growth in its specialty insurance platform, expanding third-party insurer

• Teva Pharmaceuticals Stock: Unlock Value in This Generic Drug Gem

Dr. Reddy's Laboratories (NYSE:RDY) reported what Chief Financial Officer M.V. Narasimham described as a resilient FY 2026

Astec Industries (NASDAQ:ASTE) used its 2026 Investor Day to outline a five-year growth plan centered on higher recurring revenue, digital products, operational improvements and disciplined

• 3 Undervalued Dividend Payers For Volatile Market Conditions

Radian Group (NYSE:RDN) said its first quarter of 2026 marked the company’s first reporting period as a “global multi-line specialty

• 5 Space Stocks Already Climbing Ahead of the SpaceX IPO

Redwire (NYSE:RDW) reported sharply higher first-quarter 2026 revenue and record backlog, while management said the company is increasing

Ralliant (NYSE:RAL) reported first-quarter 2026 results above the high end of its guidance and raised its full-year outlook, citing strength in Test & Measurement, continued demand in defense and

• Norwegian Cruise Line Cuts Outlook as Headwinds Build

Ready Capital (NYSE:RC) said its first-quarter 2026 results reflected continued pressure from a balance sheet repositioning plan aimed at

• D-Wave Earnings Looked Weak, But Investors May Be Missing This

Qnity Electronics (NYSE:Q) reported a record first quarter for fiscal 2026, with management citing strong demand tied to artificial

• D-Wave Earnings Looked Weak, But Investors May Be Missing This

D-Wave Quantum (NYSE:QBTS) reported a sharp increase in first-quarter bookings and said demand for its quantum computing systems has

Assembly Biosciences (NASDAQ:ASMB) Chief Medical Officer Anuj Gaggar outlined the company’s virology strategy and upcoming clinical priorities during a Bank of America-hosted discussion

• PaySafe Stock is an iGaming Growth Play After the SPAC Sell-Off

Paysafe (NYSE:PSFE) reported a stronger start to 2026, with first-quarter revenue rising 10% and adjusted earnings per share

Primo Brands (NYSE:PRMB) reported a return to comparable sales growth in the first quarter of 2026, driven by gains in retail channels, premium water brands and improving trends in its direct

Land Securities Group (LON:LAND), known as Landsec, said strong occupier demand and limited new supply helped lift occupancy across its portfolio to the highest level in more than two decades